• Clients of Cleveland Spinal Injury Attorneys May Be Eligible for Stem Cell Study

    Posted on October 26th, 2015 admin No comments

    Clients of spinal injury attorneys in Cleveland may be eligible for a new study designed to improve treatment through stem cell research.

    Rush University Medical Center scientists are researching a potential new therapy to use human embryonic stem cells to treat spinal cord injuries within 14 to 30 days of an injury. The stem cells contain progenitor cells that support nerve cells and can potentially make poorly functioning nerves function better.

    “There are currently no therapies which successfully reverse the damage seen in the more than 12,000 individuals who suffer a spinal cord injury each year in the United States alone,” Dr. Richard G. Fessler told Science Daily. Fessler is a professor of neurological surgery at Rush University Medical Center and principal investigator for the Phase 1 clinical trial involving AST-OPC1 (oligodendrocyte progenitor cells).

    “These injuries can be devastating, causing both emotional and physical distress, but there is now hope. This is a new era where we are now able to test whether a dose of stem cells delivered directly to the injured site can have an impact on motor or sensory function,” says Fessler. “If we could generate even modest improvements in motor or sensory function, it would result in significant improvements in quality of life.”

    The trial will test three escalating doses of AST-OPC1 in patients with subacute, C5-C7, neurologically-complete cervical spinal cord injury.

    “In the future, this treatment may be used for peripheral nerve injury or other conditions which affect the spinal cord, such as MS or ALS,” Fessler said.

    The trial is currently looking for patients, many of whom may be the clients of a spinal injury attorney in Cleveland.

  • Talk to Your Cleveland Spinal Injury Lawyer about the Benefits of Stem Cell Research

    Posted on November 20th, 2014 admin No comments

    Victims of spinal injury can take heart. Stem cell research may offer much needed treatments and relief. But they’ll need to be patient, as progress in this field has been slow. The Michael J. Fox Foundation for Parkinson’s Research pulled its funding from stem cell research two years ago on the grounds that it preferred to invest in research that could provide more immediate help. Still, researchers have been slowly learning how to implement stem cells in progress that has been pragmatic, if not singularly transformational. It’s enough for Cleveland spinal injury lawyers to tell their clients there is hope, but in the meantime they’ll have to learn to live with their condition and make the best of it.

    At least 4,500 clinical trials involving stem cells are working to develop treatments for heart disease, blindness, Parkinson’s, H.I.V., diabetes, blood cancers and spinal cord injuries, according to the New York Times. Early studies indicate stem cells can be delivered safely, but the real question remains on how much progress they can make when it comes to treatment.

    “Now what we want to know is: Will it work, and will it be better than what’s already out there?” Dr. Ellen Feigal, senior vice president of research and development at the California Institute of Regenerative Medicine, told the New York Times.

    The California Institute of Regenerative Medicine is the state stem cell agency which has awarded more than $2 billion towards stem cell research since 2006. It has enrolled patients in at least 10 clinical trials this year alone.

    Hope is on the horizon, but the journey is long. In the meantime, victims of spinal injuries are best left working with their Cleveland spinal injury lawyer to protect their rights, ensure a financial future and learn to best live with their condition. Life goes on, and healing progresses with time.